Global Gastrointestinal Stromal Tumor (GIST) Drug Market Insights and Forecast to 2031

Report ID: 1563962 | Published Date: Sep 2024 | No. of Page: 116 | Base Year: 2023 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Gastrointestinal Stromal Tumor (GIST) Drug market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Gastrointestinal Stromal Tumor (GIST) Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Amcasertib
Anagrelide hydrochloride CR
APG-1351
Binimetinib
Others
Segment by Application
Clinic
Hospital
Others
By Company
Ariad Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc.
Array BioPharma Inc.
Astex Pharmaceuticals, Inc.
Blueprint Medicines Corporation
Boston Biomedical, Inc.
Calithera Biosciences, Inc.
Chipscreen Biosciences Ltd
Deciphera Pharmaceuticals, LLC
F. Hoffmann-La Roche Ltd.
Horizon Pharma Plc
Immunicum AB
Jiangsu Hengrui Medicine Co., Ltd.
Kolltan Pharmaceuticals, Inc.
Natco Pharma Limited
Nerviano Medical Sciences S.r.l.
Novartis AG
Omeros Corporation
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Frequently Asked Questions
Gastrointestinal Stromal Tumor (GIST) Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Gastrointestinal Stromal Tumor (GIST) Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Gastrointestinal Stromal Tumor (GIST) Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

NADPH Oxidase 4

NADPH Oxidase 4 market is segmented by Type and by Application. Players, stakeholders, and other  ... Read More

Beta Secretase 1

Beta Secretase 1 market is segmented by Type and by Application. Players, stakeholders, and other ... Read More

Hepcidin

Hepcidin market is segmented by Type and by Application. Players, stakeholders, and other partici ... Read More

Nociceptin Receptor

Nociceptin Receptor market is segmented by Type and by Application. Players, stakeholders, and ot ... Read More